CoChat

Sitagliptin, a dipeptidyl peptidase‐4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline

Gault, V. A., Lennox, R., Flatt, P. R. · 2015 · Diabetes, Obesity and Metabolism
Cited by 141

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Aim: To examine whether prolonged dipeptidyl peptidase‐4 ( DPP‐4 ) inhibition can reverse learning and memory impairment in high‐fat‐fed mice. Methods: High‐fat‐fed mice received oral sitagliptin (50 mg/kg body weight) once daily or saline vehicle over 21 days. An additional group of mice on standard chow received saline vehicle. Energy intake, body weight, glucose and insulin concentrations were measured at regular intervals. Glucose tolerance, insulin sensitivity, novel object recognition, DPP‐4 activity, hormone analysis, hippocampal gene expression and histology were performed. Results: Sitagliptin decreased circulating DPP‐4 activity and improved glucose tolerance, glucose‐stimulated insulin secretion and insulin sensitivity, and reduced plasma triglycerides and cholesterol levels. DPP‐4 inhibition improved recognition memory (1.2‐fold increase) without affecting hypermoteric activity or anxiety levels. Improvement in memory and learning was linked to reduced immunostaining for 8‐oxoguanine and increased doublecortin staining in the hippocampus, which were indicative of reduced brain oxidative stress and increased hippocampal neurogenesis, respectively. These effects were associated with significant upregulation of hippocampal gene expression of glucagon‐like peptide‐1 ( GLP‐1 ) receptor, glucose‐dependent insulinotropic polypeptide receptor, synaptophysin, sirtuin 1, glycogen synthase kinase 3β, superdioxide mutase 2, nuclear factor (erythroid‐derived 2)‐like 2 and vascular endothelial growth factor. Total plasma and brain GLP‐1 concentrations were significantly increased after sitagliptin therapy, whereas DPP‐4 activity in brain tissue was not altered. Conclusion: These studies show that sitagliptin can reverse memory impairment in high‐fat‐fed mice and is also associated with improved insulin sensitivity, enhanced hippocampal neurogenesis and reduced oxidative stress. DPP‐4 inhibitors may therefore exhibit dual benefits by improving metabolic control and reducing the decline in cognitive function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12432

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Gault, V. A., Lennox, R., & Flatt, P. R.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2015-01-28
Volume
17
Issue
4
Pages
403-413
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2165773449
Cited by
141
References
13
FWCI
14.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.